Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

ConoGenetix Biosciences GmbH

conoGenetix is a privately owned biopharmaceutical company focused on the development of new ion channel selective peptides. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads that modulate ion channel targets - e.g. causatively involved in the generation of autoimmune diseases. Currently, conoGenetix runs a program targeting severe autoimmune disorders like Multiple Sclerosis (MS), Rheumatoid Arthritis (RA) and Vasculitis. Several peptides called cgtx-peptides within this program are in preclinical development. The leading indication for the cgtx-peptides is Vasculitis - a fatal disease strongly related to Rheumatoid Arthritis. Vasculitis is a rare disease and will be a market door opener for conoGenetix. A successful entry into phase I/IIa clinical trials at the end of this financing round will raise the valuation of the company significantly. *


Period Start 2002-01-01 established
Product Industry diagnostics (medical/biological)
Person Person Klostermann, Andreas (ConoGenetix 201204 Managing Director + Co-founder)
Region Region Martinsried
  Country Germany
  Street 19 Am Klopferspitz
  City 82152 Martinsried
  Tel +49-89-5472695-0
    Address record changed: 2020-12-02
Basic data Employees A: 1 to 10 (2014-10-21)
    * Document for �About Section�: ConoGenetix Biosciences GmbH. (4/23/12). "Press Release: ConoGenetix Announces Series A Financing Round". Martinsried.
Record changed: 2017-04-01


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for ConoGenetix Biosciences GmbH

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top